Zebing Liu

5PUBLICATIONS
24CO-AUTHORS
Molecular targetsSolid tumoursPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 22, 2026
Combined inhibition of BETs and HDACs as a potential epigenetics-based therapy for malignant rhabdoid tumor.

|Aug 09, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor.

Tom Zhang, Christopher A Febres-Aldana, Zebing Liu

|Dec 20, 2023
Rare myxoid pleomorphic liposarcoma: a case report and literature review.

Yanying Shen, Ling Zhao, Anqi Li

|Sep 26, 2021
CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.

Xiaolin Lin, Ting Han, Qing Xia

|Jun 08, 2018
Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.

Zebing Liu, Ying Cai, Yu Yang

Pageof 1

Frequent Collaborators

1 joint publications

Xiaolin Lin

1 joint publications

Liwei Wang

1 joint publications

Xiuying Xiao

1 joint publications

Lisha Wang